The Outcome of the Chemotherapy and Oncothermia for Far Advanced Adenocarcinoma of the Lung: Case Reports of Four Patients

Journals Menu

Follow SCIRP

ISSN Print: 2169-2718
ISSN Online: 2169-2726
www.scirp.org/journal/alc
E-mail: alc@scirp.org

Citations

"The Outcome of the Chemotherapy and Oncothermia for Far Advanced Adenocarcinoma of the Lung: Case Reports of Four Patients"
written by Doo Yun Lee, Joon Seok Park, Hae Chul Jung, Eun Seol Byun, Seok Jin Haam, Sung Soo Lee,
published by Advances in Lung Cancer, Vol.4 No.1, 2015

has been cited by the following article(s):

[1]	The Clinical Validation of Modulated Electro-Hyperthermia (mEHT)
	Cancers, 2023

[2]	Oncothermia is a kind of oncological hyperthermia–a review
	2020

[3]	Quo Vadis Oncological Hyperthermia (2020)?
	2020

[4]	CONCURRENT CHEMO-HYPERTHERMIA FOR RECURRENT CERVICAL CANCER
	Challenges and Solutions of Oncological …, 2020

[5]	Oncothermia in Combination with Vitamin C Infusion for Non-small Cell Lung Cancer: a Case Report
	2019

[6]	What is on the Horizon for Hyperthermic Cancer Therapy
	Journal of Traditional Medicine & Clinical Naturopathy, 2017

[7]	Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent …
	2017

[8]	DAÑO TISULAR Y CINÉTICA TUMORAL BAJO LA ACCIÓN DE LA ELECTROTERAPIA CON DIFERENTES ARREGLOS DE ELECTRODOS
	2017

[9]	Nanothermia: A heterogenic heating approach
	2016

[1]	The Clinical Validation of Modulated Electro-Hyperthermia (mEHT) Cancers, 2023 DOI:10.3390/cancers15184569

[2]	Quo Vadis Oncological Hyperthermia (2020)? Frontiers in Oncology, 2020 DOI:10.3389/fonc.2020.01690

[3]	Oncothermia in Combination with Vitamin C Infusion for Non-small Cell Lung Cancer: a Case Report Journal of Nutritional Oncology, 2019 DOI:10.34175/jno201903007

[4]	Heating Preciosity—Trends in Modern Oncological Hyperthermia Open Journal of Biophysics, 2017 DOI:10.4236/ojbiphy.2017.73010

[5]	Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis BMJ Open, 2017 DOI:10.1136/bmjopen-2017-017387

Follow SCIRP